Description
Bioven Mono (Human normal immunoglobulin) Solution for Injections 50 ml Vial №1
Composition
Bioven Mono: This solution contains Human normal immunoglobulin as the active ingredient.
Mechanism of Action
Pharmacological Properties: Human normal immunoglobulin functions by providing passive immunity to individuals with primary immunodeficiency disorders. It contains antibodies that aid in fighting infections and enhancing the immune response.
Indications for Use
Indications: Bioven Mono is specifically used for the treatment of primary immunodeficiency disorders.
Contraindications
Contraindications: It is contraindicated to use Bioven Mono in individuals with a history of severe allergic reactions to human immunoglobulins.
Side Effects
Side Effects: Common side effects may include mild reactions at the injection site, headache, or fatigue. Contact your healthcare provider if you experience any severe or persistent side effects.
Usage Instructions
Dosage and Administration: The dosage of Bioven Mono should be determined by a healthcare professional based on the patient’s individual condition and requirements. It is administered through intravenous infusion as directed by the healthcare provider.
Benefits Compared to Analogues
Benefits: Bioven Mono offers a targeted treatment approach for primary immunodeficiency disorders, providing specific immunoglobulin support tailored to individual patient needs. This can result in improved efficacy and reduced risk of adverse reactions compared to non-human immunoglobulin products.
Suitable Patient Groups
Patient Groups: Bioven Mono is suitable for use in both pediatric and elderly populations with primary immunodeficiency disorders. Dosage adjustments may be necessary based on age and specific health conditions.
Storage and Shelf Life
Storage: It is recommended to store Bioven Mono in a refrigerator at a temperature between 2°C to 8°C. Avoid freezing the product to maintain its stability and effectiveness.
Packaging Description
Packaging: Bioven Mono is available in a 50 ml vial for injections, ensuring convenient and sterile administration of the solution.
Clinical Evidence and Proven Effectiveness
Clinical Evidence: Studies have demonstrated the efficacy of human normal immunoglobulin, such as Bioven Mono, in the management of primary immunodeficiency disorders. Research published in the Journal of Clinical Immunology highlighted the positive impact of immunoglobulin replacement therapy on patients with immunodeficiencies.
